Delegate Registration 
Sponsorship Packages 
Regulatory Affairs with Cadila Pharma Ltd.
Dr. Aman Gupta has over 14 years of experience in Regulatory Affairs and Research & Development across various categories : Drugs, Biologicals, Food/Health Supplements, , Cosmetics ,Medical Devices etc.Dr. Gupta has been working closely with various National and International regulatory bodies.
In the Indian market Dr. Gupta has worked in the field of Food Supplements significantly. He has also partnered with the Industry associations for providing important inputs to the Nutraceutical/Food Supplement Regulations notified by Food Safety and Standards Authority of India(FSSAI).Globally he has been working very closely with Regulatory agencies in USA, Belarus, Middle East and Europe.
Dr. Gupta has also significant contributions in Research and Development specially in the Clinical Research domain. He has experience of Design ,Conduction, Execution and Monitoring of several Clinical Trials pertaining to Food Supplements, Cosmetics, Novel Drugs.
Currently Dr. Gupta is working as Deputy General Manager Regulatory Affairs with Cadila Pharma Ltd. and is responsible for the Regulatory Affairs and Policy Advocacy activities.
Key International Publication in 2016.
1. To Investigate Role of Glycosylated Hemoglobin(HbA1C) as a Biomarker for prediction of Dementia &Cognitive Dysfunction in Type 2 Diabetic Patients.
Aman Gupta et al., J Alzheimer’s Dis Parkinsonism 2016, 6:5(Suppl).
Brand India Inc’s superiority in technology and innovation across the globe.
Attract more FDI as mandated by “Make in India” within promising sectors of the economy.
Create a platform for Indian industry to celebrate its innovation and technology Prowess.
Create a mechanism for Government to interact with and address issues of innovative organizations.
Create a channel for foreign trade bodies to tap into Indian innovation ecosystem.
Create a national and global market for Indian industry.